Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Diabetics who control blood sugar today are more likely to have healthy feet and nerves tomorrow

13.03.2006


Effects of tight glucose control seen years later in diabetic neuropathy study



People with diabetes who keep their blood sugar in check today will probably have a far lower chance of developing foot pain or other nerve damage tomorrow, according to new research results from a national study.

In fact, the study shows that the positive effects of tight blood glucose control can be seen more than a decade later. At the end of the study period, patients who had controlled their blood sugar tightly ever since the start of the study were 51 percent less likely to have nerve problems than patients who started the study at the same time but did not have the initial 5 year period of intensive blood sugar control.


The study, published in the February issue of the journal Diabetes Care, involved 1,441 people with Type 1 diabetes, also known as juvenile diabetes. Although patients with the more common Type 2 form of diabetes were not involved, the results may have implications for the 18 million Americans with Type 2 diabetes.

Two-thirds of all people with diabetes have some degree of nerve problems, or neuropathy, related to their diabetes. The most common sign is numbness or pain in the feet and legs, which can progress over time to cause disability. Neuropathy plays a major role in 80,000 foot and leg amputations in American diabetics each year.

"This is an exciting finding that adds credence to the idea of metabolic memory, or the concept that there can be a durable effect from early and sustained efforts to keep blood sugar low," says senior author Eva Feldman, M.D., Ph.D., the DeJong Professor of Neurology at the University of Michigan Medical School and director of the U-M Neuropathy Center. "It suggests that good glucose control clearly protects patients over the long term."

The new study marks the first time that tight blood sugar control has been shown to have a long-term effect on the chance that a person with diabetes will develop neuropathy. Similar findings have been made for two other frequent complications of diabetes, retinopathy (eye disease) and nephropathy (kidney disease).

The new findings come from the Epidemiology of Diabetes Intervention and Complications (EDIC) study that grew out of the national Diabetes Control and Complications Trial (DCCT). Funded by the National Institute of Diabetes and Digestive & Kidney Diseases, the DCCT began in the 1980s by randomly assigning people with Type 1 diabetes to either tight blood-sugar control using three insulin injections per day or an insulin pump, or to more typical blood sugar control for the time, using one to two insulin injections a day. The latter group was later encouraged to adopt tight blood sugar control, and the EDIC study tracked all patients’ health.

The new paper reports results from eight years of neuropathy assessments under the EDIC study, among 1,441 DCCT participants who had no symptoms or signs of neuropathy at the end of the DCCT.

The symptoms and signs were assessed using a standardized questionnaire developed and validated by U-M researchers from the Michigan Diabetes Research and Training Center. Called the Michigan Neuropathy Screening Instrument, the questionnaire is completed by both patients -- who report symptoms such as tingling, pain, numbness, and sensitivity -- and by physicians, who complete a physical examination of the patients’ feet, including sensitivity to touch and vibration, and the presence of calluses and sores that the patients might not be able to feel because of nerve damage.

Such foot problems can become infected and lead to open wounds that can be hard to heal because of other aspects of diabetes. Unhealed infections, if bad enough, can lead to decisions to amputate toes, feet and legs. This "domino effect" starting with neuropathy and leading to infection and amputation is the reason that current guidelines call for people with diabetes to have annual foot exams.

Feldman, who led the analysis along with research nurse Catherine Martin, M.S., notes that the study looked at the percentage of participants who had any positive sign of neuropathy on their questionnaire or their foot examination each year of the EDIC study, and then separated them according to which DCCT group (tight glucose control or regular control) they had been in.

This allowed them to track the impact of prior tight glucose control, even though all the participants were encouraged to control their blood sugar tightly once they entered the EDIC phase of the project. Test results taken each year show that the two groups achieved very similar blood-sugar control in the later years of the EDIC study, with levels of a measure called A1C around 8 percent for both groups.

After the first year, 28 percent of the regular-control patients showed signs of neuropathy on their physical exam, though only 4.7 percent reported symptoms on their questionnaires. By contrast, 17.8 percent of the tight-control patients had neuropathy signs on their foot exams, and 1.8 percent reported symptoms. The difference between the two groups was highly statistically significant.

Over time, the difference between the two groups continued to be significant, although the percentage of both groups that showed signs or reported symptoms of neuropathy increased over time. By the end of the eighth year of follow-up, almost 7 percent of the participants who had been in the regular-control group reported feeling symptoms of neuropathy, compared with about 3.5 percent of the tight-control patients. And at the end of eight years, more than 26 percent of regular-control participants had signs of neuropathy on their physical exam, compared with just over 20 percent of tight-control participants.

The researchers calculated statistical likelihoods for these measures. In all, participants who had begun with tight blood-sugar control and stuck with it were 51 percent less likely to report symptoms of neuropathy, and 43 percent less likely to show signs of it, than those who had started out with regular blood-sugar control and then gone to tight control. There were also differences between the two groups in the incidence of open sores requiring medical or surgical treatment, and in incidence of amputation.

In all, says Feldman, the results reinforce a key message for all of today’s diabetes patients, though Type 2 diabetics tend to have other health problems that can interfere with the protective effects of tight sugar control. That message: Check your blood sugar levels regularly, and take steps to keep them under tight control, with few extremes of low or high sugar.

Kara Gavin | EurekAlert!
Further information:
http://www.med.umich.edu/pfund

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>